If Bisantrene becomes a replacement for Breast Cancer, is there an argument that it could replace doxorubicin in all formats?
https://www.prnewswire.com/news-releases/doxorubicin-market-size-is-expected-to-reach-138-billion-by-2024-grand-view-research-inc-602613665.html
Doxorubicin Market: Application outlook (Market revenue in USD Million, 2013 - 2024)
- Ovarian cancer
- Multiple myeloma
- Kaposi Sarcoma
- Leukemia
- Bone sarcoma
- Breast cancer
- Endometrial cancer
- Gastric cancer
- Liver cancer
- Kidney cancer
- Other cancer
Understanding RAC, page-21
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |